Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
22%
OVERLAP
BY WEIGHT
33
# OF OVERLAPPING
HOLDINGS
CANC
55
HOLDINGS
61%
ALSO IN XBI
XBI
138
HOLDINGS
24%
ALSO IN CANC
SECTOR DRIFT (CANC minus XBI)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 6.6% | 1.8% | 1.8% |
|
EXELIXIS INC | 2.9% | 1.4% | 1.4% |
|
NUVALENT, INC. CLASS A | 3.3% | 1.4% | 1.4% |
|
HALOZYME THERAPEUTICS INC | 1.3% | 1.1% | 1.1% |
|
COGENT BIOSCIENCES INC | 4.4% | 1.0% | 1.0% |
CANC Overweight Relative to XBI
|
ELI LILLY & CO | 5.1% |
|
REVOLUTION MEDICINES, INC. | 4.8% |
 |
NOVARTIS AG | 4.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 4.2% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 3.6% |
|
MERCK & CO. INC. | 3.5% |
|
COGENT BIOSCIENCES INC | 3.4% |
|
BRISTOL-MYERS SQUIBB CO | 3.4% |
 |
ASTRAZENECA PLC | 3.1% |
|
JOHNSON & JOHNSON | 3.0% |
CANC Underweight Relative to XBI
|
TG THERAPEUTICS INC | -2.1% |
|
TWIST BIOSCIENCE CORP. | -2.0% |
|
TRAVERE THERAPEUTICS, INC. | -2.0% |
 |
ALKERMES PLC | -1.8% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -1.5% |
|
KRYSTAL BIOTECH, INC. | -1.5% |
|
BEAM THERAPEUTICS, INC. | -1.4% |
|
VERACYTE INC | -1.4% |
|
CYTOKINETICS INC | -1.4% |
|
NEUROCRINE BIOSCIENCES INC | -1.3% |